Trial Profile
To evaluate the effects of Isavucanazole on patients with Hematologic malignancy : A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Isavuconazole (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- 13 Oct 2016 New trial record